EFFECT OF MYO INOSITOL ON INSULIN RESISTANCE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME EFECTO DEL MYO INOSITOL EN LA RESISTENCIA A LA INSULINA EN MUJERES CON SINDROME DE OVARIO POLIQUISTICO

Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder that affects women of reproductive age and is strongly associated with insulin resistance (IR) and hormonal imbalances. IR plays a critical role in the patohopysiology of PCOS, contributing to reproductive dysfunction, menstrual irregularities, and long-term cardiometabolic complications. Convemtional treatment such as metformin are effective but often poorly tolerated. In this context, myo-inositol has emerged as promising alternative due to its role in insulin signaling and its favorable safety profile.